Literature DB >> 7198867

Familial Mediterranean fever associated with menstruation. Efficacy of intermittent colchicine therapy.

A M Milano.   

Abstract

The majority of patients with familial Mediterranean fever have a random pattern of attacks without a clear prodrome. Continuous prophylaxis with colchicine has been shown to reduce the frequency of attacks. It is generally considered undesirable, however, to expose young patients to the potential adverse effects of continuous colchicine prophylaxis. The alternative of intermittent short courses of colchicine during acute attacks is often ineffective in patients without a clear prodrome. Case reports of patients with a pattern of attacks occurring 12-24 hours after the onset of menstrual bleeding have appeared. Such patients should be ideal candidates for intermittent colchicine therapy. A review of the literature reveals that a consistent pattern of attacks closely following the onset of menstruation is not uncommon. Such a patient is described who has responded completely to short courses of colchicine begun at the first sign of menstrual bleeding.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198867

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients.

Authors:  Servet Akar; Mujde Soyturk; Fatos Onen; Mehmet Tunca
Journal:  Rheumatol Int       Date:  2005-09-24       Impact factor: 2.631

2.  Regular abdominal pain and fever in each menstruation onset: an unusual menses-associated familial Mediterrenean fever attacks and a favor result on colchicine treatment.

Authors:  Nurşen Düzgün; Aşkin Ateş; Serpil Tuna
Journal:  Rheumatol Int       Date:  2005-09-23       Impact factor: 2.631

3.  Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.

Authors:  Kazusato Hara; Yushiro Endo; Midori Ishida; Yuya Fujita; Sosuke Tsuji; Ayuko Takatani; Toshimasa Shimizu; Remi Sumiyoshi; Takashi Igawa; Masataka Umeda; Shoichi Fukui; Ayako Nishino; Shin-Ya Kawashiri; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Hideki Nakamura; Tomoki Origuchi; Kiyoshi Migita; Atsushi Kawakami; Tomohiro Koga
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.